Clinical LLMs & Multimodal AI · 2026-11-18 · PubMed / JMIR dermatology
LLM Chatbot Offers Promising, Yet Flawed, Allergen Avoidance Guidance in Contact Dermatitis
A recent quantitative evaluation study explored the utility of a Large Language Model (LLM) chatbot, specifically GPT-4, in providing allergen-free product recommendations for patients with contact dermatitis. The study assessed the LLM's ability to recommend products free of 30 common allergen groups found in international standard patch tests. While the chatbot demonstrated a high proportion of valid responses, particularly for cosmetics and medications, clinicians must recognize its limitations, especially concerning complex allergens prone to cross-reactivity.
Over a period from September 2023 to January 2024, GPT-4 was prompted to suggest five allergen-free products for each allergen group, utilizing three distinct question formats. Dermatologists manually reviewed and categorized 2250 responses for validity, invalidity, cross-reactions, unknown status, and unresponsiveness. The findings indicate a significant potential for LLM tools to assist in allergen avoidance counseling, albeit with a crucial need for human verification and oversight.
Urology AI · 2026-11-17 · PubMed / Current opinion in urology
AI and Augmented Reality Revolutionize Robotic Urology: Evidence from Radical Prostatectomy and Partial Nephrectomy
Recent advancements in image-guided and augmented reality (AR)-assisted robotic surgery are transitioning from static preoperative planning to dynamic, automated intraoperative navigation, particularly within urologic oncology. This review highlights significant progress over the past 12-18 months in utilizing three-dimensional (3D) virtual models, AR overlays, and artificial intelligence (AI)-driven registration to enhance precision and improve patient outcomes. The primary focus is on applications that have moved beyond initial descriptions to comparative and randomized controlled trials, validating the utility of these technologies in complex procedures like radical prostatectomy and partial nephrectomy.
In radical prostatectomy, a randomized controlled trial comparing AI-driven 3D-AR guidance with traditional cognitive MRI guidance demonstrated superior outcomes. Similarly, in partial nephrectomy, the integration of 3D models for anatomical and perfusion planning, coupled with AI-based automated registration, has shown favorable results across various comparative and meta-analytic studies, including in challenging cases such as horseshoe kidneys and totally endophytic tumors. These findings suggest a growing, albeit still procedure-limited, role for image-guided robotic surgery, supported by increasing independent replication.
Oncology AI · 2026-11-16 · PubMed / Open medicine (Warsaw, Poland)
AI-Driven Gene Signatures from Succinate Metabolism Enhance Early HCC Diagnosis and Prognostic Stratification
A recent study published in Open Medicine leveraged transcriptomic and clinical data to identify succinate metabolism-related gene signatures (SMRGs) for improved diagnosis and prognostic stratification in early-stage hepatocellular carcinoma (HCC). Utilizing machine learning algorithms, researchers identified 24 differentially expressed SMRGs (DESMRGs) that exhibit significant diagnostic potential. Specifically, four genes—CDKN2A, LIFR, NTF3, and PVALB—demonstrated robust capabilities in distinguishing early HCC with AUC values exceeding 0.70.
The investigation further revealed that consensus clustering based on SMRG profiles could stratify early HCC patients into two distinct subgroups characterized by divergent survival outcomes and pathway activities. A robust six-gene risk score model was subsequently developed and externally validated, effectively categorizing patients into high- and low-risk groups. This model not only provided prognostic insights but also elucidated associations with the tumor microenvironment, immune response, and drug sensitivity, offering a comprehensive tool for clinical decision-making.
Clinical LLMs & Multimodal AI · 2026-11-15 · PubMed / Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
LLM Performance in PMOS/PCOS Information: DeepSeek-V4 Outperforms GPT-5.5 and Gemini 3.5 in Clinician-Rated Quality and Empathy
A recent study evaluated the information quality, readability, transparency, and perceived empathy of responses from three widely accessible large language models (LLMs)—DeepSeek-V4, GPT-5.5, and Gemini 3.5—to clinician-formulated questions regarding polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS). The study found significant differences in performance among the LLMs, with DeepSeek-V4 consistently receiving higher clinician ratings across multiple quality and empathy metrics.
Thirty-three distinct English questions, crafted by clinicians and using established PCOS terminology, were submitted to each LLM. Two independent clinicians then rigorously assessed the 99 archived responses using standardized tools such as the DISCERN instrument for information quality, EQIP for transparency, and JAMA benchmarks. Readability was quantitatively analyzed using six different indices, while perceived empathy was subjectively rated. The methodological approach involved matched comparisons using Friedman tests, paired signed-rank permutation comparisons, and Holm correction to account for multiple comparisons.
Clinical LLMs & Multimodal AI · 2026-11-14 · PubMed / Handbook of experimental pharmacology
PROTACs Advance: AI and 'Linkerology' Reshape 'Undruggable' Target Degradation
Proteolysis-targeting chimeras (PROTACs) are fundamentally altering drug discovery by shifting from traditional occupancy-driven inhibition to event-driven protein degradation. This allows for the targeting of proteins previously considered 'undruggable' due to a lack of suitable binding pockets for conventional small molecule inhibitors. The inherent heterobifunctional structure of PROTACs, however, often places them in the 'beyond-Rule-of-5' chemical space, characterized by high molecular weights and complex polar surface areas, posing significant challenges to oral bioavailability and pharmacokinetic properties.
Recent advancements, meticulously analyzed in this research, focus on multidimensional optimization strategies to overcome these limitations. These include sophisticated 'linkerology' – transforming linkers from simple connectors into active modulators of ternary complex formation, affecting thermodynamics, kinetics, and metabolic stability. Furthermore, engineering approaches for both target protein ligands and E3 ligase ligands are being refined, incorporating structure-activity relationship (SAR) improvements, allosteric targeting to bypass resistance, and strategic optimization of pharmacokinetic profiles. The integration of concepts such as molecular chameleonicity, active transport pathways, and particularly, AI-driven generative design, provides a robust theoretical framework to address the critical challenge of oral bioavailability for these next-generation therapeutics.
Oncology AI · 2026-11-13 · PubMed / Proceedings of the National Academy of Sciences of the United States of America
Deep Learning Identifies p38α MAPK-MK2 Axis as Driver of Ovarian Cancer Chemoresistance via Nuclear Actin Remodeling
A novel deep learning pipeline, nFANet, has been instrumental in uncovering a critical mechanism by which ovarian cancer cells develop chemoresistance to platinum-based therapies. The study utilized nFANet for high-throughput analysis of nuclear F-actin assembly, revealing that platinum-based chemotherapy robustly induces this assembly. This process, facilitated by nuclear F-actin, is known to enhance DNA damage repair, thereby contributing to treatment failure in various cancers.
Through a combination of nFANet and a subsequent kinome screening, the p38α MAPK-MK2 signaling pathway was identified as a key upstream regulator of chemotherapy-induced nuclear F-actin assembly. Mechanistically, this pathway promotes formin-mediated nuclear F-actin polymerization. Crucially, pharmacological or genetic disruption of the p38α MAPK-MK2 pathway significantly enhanced the sensitivity of ovarian cancer cells to platinum-based chemotherapy. These findings suggest a potential therapeutic strategy to overcome chemoresistance in ovarian cancer by targeting this specific molecular axis.
Oncology AI · 2026-11-12 · PubMed / ChemMedChem
Stimuli-Responsive Hydrogels: AI-Accelerated Design for Targeted Cancer Therapy
Stimuli-responsive hydrogels (SRHs) represent a significant advancement in targeted cancer therapeutics, offering precise, site-specific drug delivery by reacting to tumor-specific microenvironmental cues. This emerging technology leverages abnormal physiological conditions within the tumor, such as altered pH, redox potential, elevated temperature, specific enzymatic activity, or light exposure, to trigger controlled release of therapeutic agents. The integration of polymer chemistry and nanotechnology has enabled the creation of sophisticated SRH platforms, including injectable systems and hybrid nanocomposites, designed for enhanced therapeutic efficacy and reduced systemic toxicity.
Recent advancements, critically reviewed in ChemMedChem, highlight successful in vitro and in vivo demonstrations of highly efficient, stimulus-triggered drug release leading to improved therapeutic outcomes. Beyond their immediate therapeutic applications, future perspectives emphasize the crucial role of Artificial Intelligence (AI) in accelerating the rational design and optimization of these biomaterials. AI-assisted material design, coupled with computational modeling and integration with bioelectronic interfaces, promises to unlock new avenues for real-time monitoring and adaptive, personalized cancer treatment strategies.
Clinical LLMs & Multimodal AI · 2026-11-11 · PubMed / JMIR medical informatics
Explainable AI Predicts ED Hospital Admissions with High Accuracy, Enhancing Triage and Resource Allocation
A recent retrospective cohort study from McGill University Health Centre demonstrated the efficacy of explainable machine learning models, particularly XGBoost, in predicting hospital admissions directly from emergency department (ED) triage data. The study, encompassing over half a million adult ED visits from two academic hospitals between 2015 and 2022, aimed to address limitations of prior admission prediction studies by incorporating a broader set of routinely collected structured data, ensuring model calibration, and providing explainability.
The research identified key predictors including age, Canadian Triage and Acuity Scale (CTAS) scores, arrival mode, and historical hospitalization frequency. The XGBoost model achieved an impressive Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.86, with a sensitivity of 0.67 and specificity of 0.86, outperforming a logistic regression baseline. These findings suggest that AI-powered tools integrated at the point of triage could significantly improve operational efficiency, facilitate proactive resource allocation, and potentially alleviate ED overcrowding in urban tertiary care settings.
Hematology AI · 2026-11-10 · PubMed / Hematology (Amsterdam, Netherlands)
Precision Medicine Roadmap for Monoclonal Gammopathy of Clinical Significance (MGCS) in the AI Era
Monoclonal Gammopathy of Clinical Significance (MGCS) represents a crucial paradigm shift in plasma cell disorder classification, moving beyond the benign/malignant dichotomy. Defined by a small B-cell or plasma cell clone that does not meet criteria for overt malignancy but secretes a pathogenic paraprotein causing significant end-organ damage, MGCS necessitates a targeted, precision medicine approach. This comprehensive review synthesizes current understanding of paraprotein-mediated organ injury mechanisms, outlines the diverse clinical manifestations, integrates modern diagnostic advancements, and proposes a roadmap for precision therapeutic intervention.
The review conducted a structured narrative analysis of literature from PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library, spanning from inception to September 30, 2026. The search focused on terms related to MGCS, MGUS, MGRS, MGNS, AL amyloidosis, paraprotein, and clone-directed therapy. Inclusion criteria encompassed peer-reviewed original studies, guidelines, consensus reports, and selected case series/reports. The extracted data covered pathophysiology, clinical phenotypes, diagnostic strategies, treatment modalities, and patient outcomes. Due to the inherent heterogeneity of the included studies, a meta-analysis was not feasible; instead, evidence was narratively synthesized with qualitative certainty ratings, emphasizing the complex and multifaceted nature of MGCS.
Clinical LLMs & Multimodal AI · 2026-11-09 · PubMed / Advances in health information science and practice
Predictive Analytics and AI Automation Alleviate Clinician EHR Burden and Burnout: A Systematic Review
A recent systematic review, published in "Advances in Health Information Science and Practice," investigated the impact of predictive analytics and workflow automation, particularly ambient AI documentation, on administrative burden and clinician burnout within US clinical settings. The study addressed the pervasive issue of Electronic Health Record (EHR)-related administrative overload, which significantly contributes to clinician burnout despite EHRs' intended benefits in quality and safety. The review synthesized findings from a comprehensive search across PubMed, CINAHL, and Embase, ultimately including 7 eligible studies from 520 initial records.
The findings suggest that integrating AI-driven tools, such as ambient AI documentation platforms and inbox prioritization systems, can lead to measurable improvements. Specifically, ambient AI was associated with a 10%-30% reduction in documentation time. While after-hours EHR activity showed varied results, several multi-site implementations reported positive impacts on validated burnout measures and cognitive task load. AI-driven inbox prioritization also demonstrated reductions in message review time, indicating a potential pathway to mitigate administrative fatigue. The review underscores the nascent but promising role of these technologies in optimizing clinical workflows and enhancing clinician well-being.
Clinical LLMs & Multimodal AI · 2026-11-08 · PubMed / Medical education online
Mitigating AI Hallucinations in LLMs: A Scoping Review for Clinical and Educational Integration
Large Language Models (LLMs) are increasingly integrated into medical education and healthcare, yet their utility is significantly hampered by 'AI hallucinations' – outputs that are plausible but factually incorrect, unsupported, or fabricated, including erroneous citations. These inaccuracies pose substantial risks to educational integrity, clinical decision-making, and patient safety. A comprehensive scoping review, adhering to Joanna Briggs Institute and Arksey and O'Malley methodologies, has systematically mapped the evidence on the nature, detection, mitigation, and governance implications of these hallucinations.
The review identified 21 relevant sources from a pool of 2,051 records published between January 2018 and July 2026. This selection included five empirical studies evaluating LLM performance and 16 conceptual or review-based articles. The synthesis categorized findings into five major themes: conceptualization of hallucinations, detection and validation methods, mitigation strategies, educational implications, and governance frameworks. Key strategies to reduce hallucination risks include retrieval-augmented generation (RAG), structured prompt engineering, robust output verification, and essential human oversight, emphasizing that these are not just technical issues but multidimensional challenges requiring a comprehensive, multilayered approach for safe implementation.
Clinical LLMs & Multimodal AI · 2026-11-07 · PubMed / Molecular medicine reports
Gene Therapy for Genetic Epilepsy: A Paradigm Shift from Symptomatic Control to Mechanistic Correction
Genetic epilepsies, often monogenic with well-defined molecular mechanisms, are poised for a significant therapeutic shift from seizure control to mechanism-driven correction via gene therapy. A recent review comprehensively analyzed five nucleic acid-based strategies: gene supplementation, endogenous gene expression enhancement, gene silencing, DNA editing, and RNA editing. The selection of an appropriate intervention is critically dependent on variant-specific functional consequences, differentiating between loss-of-function (LOF) and gain-of-function (GOF) mutations. This analytical framework aims to guide clinical decision-making by evaluating the mechanisms, suitability, cell-type specificity, delivery vectors, and safety profiles of each approach.
The review integrated evidence from animal models, induced pluripotent stem cell (iPSC)-derived neurons, organoids, and ongoing clinical trials. It highlighted that antisense oligonucleotides (ASOs) and regulatory adeno-associated viral (AAV) approaches currently demonstrate the most advanced clinical validation, primarily due to mature delivery platforms and manageable safety profiles. While other strategies like DNA and RNA editing hold promise for durable disease modification, they require further research into delivery efficiency and long-term safety, underscoring the ongoing translational challenges in this rapidly evolving field.
Clinical LLMs & Multimodal AI · 2026-11-06 · PubMed / JMIR formative research
LLMs for Atrial Fibrillation Patient Education: Cardiologist vs. Non-Medical Professional Perceptions of ChatGPT and Google Gemini Quality
A recent pilot study published in JMIR Formative Research comparatively analyzed the quality of atrial fibrillation (AF) explanations generated by ChatGPT and Google Gemini, specifically tailored for patient education. The study aimed to assess the overall quality of these AI platforms, compare their responses, and identify differences in perception between cardiologists and non-medical professionals. The prompt, "Explain atrial fibrillation and how to treat it to a patient," was used to generate responses from both AI models. These responses were then evaluated by a cohort of 28 participants, comprising cardiologists/cardiology fellows and non-medical college graduates, using a survey derived from the Patient Education Materials Assessment Tool (PEMAT) and DISCERN criteria, rated on a 5-point Likert scale.
The findings indicated no significant overall quality difference between ChatGPT and Google Gemini for AF education. However, crucial discrepancies emerged in how different participant groups evaluated specific aspects. Cardiologists rated AI responses higher for perceived bias and for explaining the consequences of untreated AF, while non-medical professionals favored structural and organizational features such as visual cues, informative headers, concise sections, identifiable patient actions, and references to additional resources. This suggests that while both platforms are viable, their utility in clinical settings requires careful consideration of the target audience and a balanced evaluation by specialists.
Regulatory & FDA Approvals · 2026-11-05 · PubMed / Australian health review : a publication of the Australian Hospital Association
Operationalizing AI Governance in Healthcare: A Qualitative Study of Staff Perspectives
A qualitative study conducted within a major Australian healthcare organization sheds light on the critical need for robust artificial intelligence (AI) governance structures. The study, involving 23 semi-structured interviews with diverse healthcare staff from strategic leadership to operational delivery, revealed that AI governance is perceived as a continuous, multifaceted organizational function, not a singular approval event. Participants highlighted existing governance processes as fragmented and ill-equipped for the unique ethical, technical, and operational challenges presented by AI.
The research identified five core, interrelated domains essential for effective AI governance in clinical settings: risk assessment, infrastructure and data management, ethical considerations, organizational capability and culture, and dedicated governance structures. The findings emphasize that successful integration of AI into healthcare requires clear pathways, defined accountabilities, and sustained oversight across all these domains to ensure safe and responsible deployment. This study provides a foundational understanding for healthcare organizations aiming to operationalize AI safely and responsibly.
Clinical LLMs & Multimodal AI · 2026-11-04 · PubMed / Gut microbes
Rifamycin MMX Shows Minimal Impact on Gut Resistome in Cirrhosis, Trends Towards Reduced Vancomycin Resistance
A double-blind, placebo-controlled clinical trial, RIVET, investigated the effects of rifamycin SV MMX (RiVM) on gut microbial antibiotic resistance genes (ARGs) in patients with compensated cirrhosis. Given that ARG carriage is linked to poorer outcomes in cirrhosis, and prior preclinical data suggested rifaximin might expand ARGs, this study aimed to clarify RiVM's impact. The trial involved 30 patients (15 RiVM, 15 placebo) who underwent shotgun metagenomic sequencing before and after 30 days of therapy.
Key findings indicate that RiVM induced minimal perturbation of the gut resistome, showing no significant increase in ARGs compared to placebo after false discovery rate (FDR) adjustment. Intriguingly, there was a trend towards reduced vancomycin resistance-associated ARGs, specifically vanW and vanT operon-associated genes, post-RiVM exposure. While some Enterobacteriaceae-associated multidrug efflux regulators (e.g., evgS, emrK, mdtA) nominally increased, these did not sustain significance after FDR correction. The study concluded that RiVM did not enrich antimicrobial resistance genes or lead to increased infections over 30 days in this patient cohort.
Dermatology AI · 2026-11-03 · PubMed / Biomedizinische Technik. Biomedical engineering
AI-Powered YOLOv11 Model Achieves High Accuracy in Vitiligo Lesion Segmentation via Standardized Photography
A novel deep learning framework, leveraging the YOLOv11 architecture, has demonstrated high accuracy in automatically segmenting vitiligo lesions from standardized clinical photographs. This development addresses a critical need for reproducible and objective quantification of vitiligo lesions, which is often a challenge in clinical practice due to inter-observer variability and subjective assessment methods. The study utilized a dataset of standardized photographs from 18 patients, captured at baseline, 3 months, and 6 months, under strict controlled imaging conditions including fixed lighting, camera settings, and color calibration. Expert dermatologists provided ground truth lesion masks for training and validation.
Clinical LLMs & Multimodal AI · 2026-11-02 · PubMed / Rhode Island medical journal (2013)
AI Chatbot Performance in Orthopedic Education: GPT-4o Outperforms AAOS Members in Adult Reconstruction
A recent study published in the Rhode Island Medical Journal evaluated the performance of seven contemporary AI chatbots on 55 multiple-choice questions from the AAOS ResStudy question bank, focusing on adult reconstruction. The objective was to assess the accuracy, response time, and citation reliability of these AI models when confronted with clinically oriented orthopedic questions. Overall, the chatbots achieved a moderate accuracy of 67.5%, with significant variability among models and question types.
Notably, GPT-4o demonstrated the highest accuracy at 80%, surpassing the average performance of AAOS members, who scored 75% on the same questions. Co-Pilot secured the second-best performance at 70.9%. The study meticulously categorized questions by anatomic region, concept (clinical presentation, prognosis, management), and AAOS-defined difficulty, revealing that AI chatbots excelled in descriptive knowledge (Clinical Presentation) but struggled with complex applied reasoning, such as prognosis and management. The findings suggest a valuable supplementary role for AI in orthopedic education, while highlighting areas needing further development.
Oncology AI · 2026-11-01 · PubMed / Annals of the New York Academy of Sciences
LLM-Driven Adaptive Optimization for Seed Implant Brachytherapy Planning
A novel framework integrating a large language model (LLM) for adaptive weight optimization in seed implant brachytherapy (SIBT) planning has been proposed and retrospectively validated. The study addresses the clinical challenge of manual, often suboptimal, adjustment of objective function weights during SIBT planning. By leveraging a locally deployed DeepSeek-R1 LLM within an iterative optimization loop, this framework aims to enhance efficiency and improve treatment plan quality.
The LLM-assisted approach iteratively evaluates brachytherapy plan quality and suggests refined objective function weights until predefined convergence criteria are met. This process is further augmented by a clinical knowledge base queried via retrieval-augmented generation (RAG), providing domain-specific reasoning capabilities to the LLM. Retrospective validation on 23 head-and-neck SIBT patient cases demonstrated the LLM framework's ability to maintain clinical target volume (CTV) coverage while concurrently reducing excessive target dose compared to conventional fixed-weight planning. Favorable numerical trends in organ at risk (OAR) dose metrics were also observed in a subset of eight patients with available OAR contours, indicating potential for improved normal tissue sparing.
Oncology AI · 2026-10-31 · PubMed / FASEB journal : official publication of the Federation of American Societies for Experimental Biology
AI-Derived Senescence Signature Stratifies Breast Cancer Prognosis and Immunotherapy Response
A novel senescence-related signature (SRS), developed through an integrative multi-omics and deep learning pathology approach, has demonstrated significant utility in stratifying breast cancer patients into distinct prognostic groups and predicting their response to immunotherapy. This study leveraged whole-slide pathology images, bulk transcriptomic profiles, single-cell RNA sequencing, spatial transcriptomics, and comprehensive clinical data to characterize senescence-associated features within the breast cancer microenvironment. The constructed SRS, derived from machine learning survival models applied to quantitative pathology features, consistently identified high-SRS patients with significantly poorer survival outcomes across internal TCGA-BRCA cohorts.
The research further elucidated the cellular localization of senescence activity, predominantly in epithelial and endothelial cells, with fibroblasts playing a key role in mediating intercellular communication, particularly related to collagen. Crucially, tumors classified as low-SRS exhibited enhanced immune-cell infiltration, elevated immune-checkpoint expression, and more favorable predicted immunotherapy responses based on Tumor Immune Dysfunction and Exclusion (TIDE) and immunophenoscore (IPS) profiles. This integrated approach not only provides a powerful prognostic and predictive tool but also identifies specific senescence-associated biomarkers, such as STARD10, as potential therapeutic targets.
Clinical LLMs & Multimodal AI · 2026-10-30 · PubMed / Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
AI in Precision Psychiatry: Navigating Biomarker Discovery from Concept to Clinic
The field of psychiatric biomarker discovery has long been hampered by challenges including suboptimal phenotypic characterization and limited cohort sizes. Recent advancements in artificial intelligence (AI), particularly large language models (LLMs) and self-supervised learning, are poised to revolutionize this landscape by transforming vast amounts of unstructured clinical text into quantifiable data and extracting insights from routinely collected, unlabeled psychiatric signals. This review highlights AI's role in the early stages of biomarker identification, from molecular interpretation to candidate generation.
While AI demonstrates significant potential in identifying novel psychiatric biomarkers, a critical gap remains between computational discovery and clinical utility. The review emphasizes an inherent asymmetry: AI can rapidly generate biomarker candidates, but the rigorous, costly process of clinical validation for real-world application remains largely unaddressed by AI itself. The authors propose a structured, six-stage framework to bridge this gap, delineating the journey from intended clinical use and measurement validity to model evaluation, comparative utility, and ultimately, monitored deployment. This framework clarifies where AI can accelerate discovery and where traditional clinical validation is indispensable.
Regulatory & FDA Approvals · 2026-10-28 · PubMed / Clinical chemistry and laboratory medicine
Prague 2025 Consensus: New Reporting Standards for AI-Driven Diagnostic Performance
The Prague 2025 consensus introduces a critical new checklist for reporting indirect outcome studies of Model 1b Analytical Performance Specifications (APS), a framework designed to evaluate the clinical impact of diagnostic test performance. This initiative addresses a significant gap in methodological guidance for studies assessing how analytical variations in diagnostic tests influence clinical classifications and subsequent treatment decisions. While Model 1b APS indirectly assesses health outcomes, it provides a crucial intermediate step to ensure diagnostic accuracy aligns with patient care needs, especially in the rapidly evolving landscape of AI-augmented diagnostics.
The developed checklist, a result of expert workshops and collaborative meetings, comprises 17 essential items. Importantly, it integrates and cross-references 25 items from the 2025 STAndards for Reporting Diagnostic accuracy studies using Artificial Intelligence (STARD-AI). This integration underscores the growing intersection of laboratory medicine standards and AI validation. The aim is to establish robust, scientifically valid, and transferable methodologies for Model 1b APS, ensuring consistency and reliability across diverse healthcare settings and applications that increasingly incorporate AI.
Clinical LLMs & Multimodal AI · 2026-10-27 · PubMed / Current opinion in neurology
AI and Digital Technologies Transforming Multiple Sclerosis Neurorehabilitation
Recent advancements in neurorehabilitation for Multiple Sclerosis (MS) are shifting towards earlier, personalized, and technology-supported interventions. While pharmacological treatments have evolved, a significant number of individuals with MS (pwMS) continue to face complex symptom burdens, functional limitations, and reduced quality of life. This review emphasizes the integration of routine, multidimensional screening that extends beyond symptom severity to include functional status, participation restrictions, and social determinants of health (SDoH). The embrace of digital health technologies, such as wearables, remote monitoring, and AI-assisted assessments, offers new avenues for more ecologically valid and accessible evaluation of pwMS.
The emerging paradigm posits neurorehabilitation as a fundamental component of comprehensive MS care, advocated for initiation early in the disease course rather than as a late-stage intervention. Exercise programs, cognitive rehabilitation, psychological therapies, and vocational rehabilitation are showing benefits across physical, cognitive, emotional, and fatigue domains, ultimately improving quality of life. Telerehabilitation and technology-supported approaches like virtual reality (VR), exergaming, and neuromodulation are proving instrumental in enhancing access to care and improving patient outcomes, despite ongoing needs for further research into their optimal application and widespread implementation.
Radiology AI · 2026-10-26 · Nature Cancer / PubMed
GEMINI: AI-Supported Breast Screening Finds Additional Cancers in an NHS Evaluation
Additional cancers detected after a routine mammography reading are a clinically important test of AI's contribution to screening. GEMINI examined this within an operating NHS service, combining prospective assessment with simulations of different reading arrangements.
The study's central contribution is its examination of how the same system performs when placed at different points in the screening pathway. Its detection findings and workload projections describe different parts of that evaluation and require separate interpretation.
Cardiology AI · 2026-10-26 · JACC: Heart Failure / PubMed
LINK-HF2: Wearable AI Monitoring Reaches Clinical Testing in Post-Discharge Heart Failure Care
Continuous wearable monitoring offers a way to detect physiological change after discharge for heart failure. Whether those signals lead to fewer admissions depends on the complete clinical intervention, including how notifications are interpreted and acted upon.
LINK-HF2 tested that intervention in a randomized feasibility study. Its results support the practicality of studying AI-guided monitoring while leaving the effect on clinical events unresolved.
Ophthalmology AI · 2026-10-26 · JAMA Ophthalmology / PubMed
CaptureTumor: Smartphone AI Screening Connects Ocular Lesion Images With Confirmed Malignancies
Moving an image model from specialist equipment to a smartphone changes the conditions under which it must operate. CaptureTumor examined that transition within a pathway that included guided photography, automated risk assessment and clinical referral.
The JAMA Ophthalmology report connects screening activity with histopathological confirmation. Its findings are relevant to ophthalmic detection services, with important distinctions between model discrimination, participation and population-level effectiveness.
Stroke & Neurology AI · 2026-10-26 · BMJ / PubMed
GOLDEN BRIDGE II: AI-Supported Stroke Care Reduces Vascular Events Across 77 Hospitals
GOLDEN BRIDGE II tested a decision-support intervention across a hospital stroke pathway, extending evaluation beyond image-recognition performance to subsequent vascular events. The intervention combined AI-assisted imaging, classification of stroke causes and evidence-based treatment recommendations.
Its findings provide clinical-outcome evidence for the tested package. Interpreting that evidence requires keeping the combined intervention and hospital-level randomization in view.
Clinical LLMs & Primary Care · 2026-10-26 · Nature Medicine / PubMed
Kenya's Primary-Care AI Trial Improves Documentation Without a Significant Treatment-Failure Benefit
A pragmatic trial in Kenyan primary care examined whether LLM assistance inside an electronic medical record improved outcomes after the consultation. The Nature Medicine study found better clinical documentation, while its primary treatment-failure endpoint did not differ significantly.
The combination is clinically informative. Documentation is a measured part of care, but an improvement in recorded information and an improvement in subsequent patient outcomes remain distinct findings.
Surgery & Patient Communication AI · 2026-10-26 · npj Digital Medicine
Prostate Surgery Trial Reports Lower Anxiety After LLM-Assisted Preoperative Communication
Preoperative communication has to address both information needs and uncertainty around a planned operation. A randomized phase II trial examined whether personalized LLM responses, delivered before the usual physician discussion, changed anxiety, communication time and perceived workload.
The npj Digital Medicine report evaluates AI as an addition to a defined clinical encounter. Its findings concern the communication process, with the face-to-face discussion retained within the intervention.
Pathology AI · 2026-10-26 · PubMed / Virchows Archiv : an international journal of pathology
Navigating Histopathology Grey Zones: A Medicolegal Framework for Breast Pathology in the AI Era
The increasing integration of advanced technologies like digital pathology, molecular testing, and artificial intelligence, coupled with evolving diagnostic thresholds, presents significant challenges to defining the 'standard of care' in histopathology. This review proposes a structured contextual diagnostic framework to address the medicolegal implications of diagnostic variability, particularly in 'grey zone' cases. Focusing on breast pathology as a model, the framework aims to provide a more consistent and defensible approach to evaluating histopathological diagnoses retrospectively.
The authors synthesize existing pathological, professional, and legal principles to establish a conceptual contextual diagnostic standard. This standard shifts the focus from identifying a single, retrospectively 'optimal' diagnosis to acknowledging a range of diagnostically reasonable interpretations. The core tenets involve evaluating the original diagnosis based on the 'reasonable pathologist' peer standard, considering the diagnostic context at the time of reporting, and recognizing inherent diagnostic variability.
Oncology AI · 2026-10-25 · PubMed / DEN open
AI-Aided Detection for Missed Gastric Cancer Post-ESD Surveillance
This forthcoming study evaluates the utility of computer-aided detection (CAD) systems in identifying residual or recurrent gastric cancer following endoscopic submucosal dissection (ESD). Given the critical importance of complete resection and vigilant post-procedure surveillance, the potential for subtle, missed lesions remains a significant clinical challenge. Traditional endoscopic follow-up relies heavily on endoscopist experience and visual acuity, which can be limited by lesion morphology, inflammatory changes, or scar tissue post-ESD.
The research aims to ascertain how an AI-powered CAD system can augment the detection capabilities of endoscopists, thereby improving the accuracy and consistency of post-ESD surveillance. By leveraging advanced image analysis, the CAD system is hypothesized to highlight suspicious areas that might otherwise be overlooked, potentially leading to earlier diagnosis of recurrence or incomplete resection and subsequent intervention. The study's focus is on enhancing the diagnostic yield in a high-risk patient population where timely intervention is paramount for improving long-term outcomes.
Gastroenterology AI · 2026-10-24 · PubMed / DEN open
AI Model Demonstrates Feasibility for Objective Visualization Quality During Cholangioscopy-Guided Lithotripsy
Cholangioscopy-guided lithotripsy is a critical endoscopic procedure for managing complex bile duct stones. However, the intraprocedural assessment of visualization quality, crucial for efficacy and safety, traditionally relies on subjective expert judgment. This subjectivity can lead to variability in stone clearance rates and potential complications.
A recent proof-of-concept study explored the feasibility of integrating a deep-learning model to provide objective, real-time assessment of visualization quality during cholangioscopy-guided lithotripsy. The research aimed to mitigate the inherent human variability in evaluating imaging clarity, field of view, and artifact presence, thereby enhancing procedural standardization. The model's development represents a significant step toward improving technical performance metrics and optimizing clinical outcomes in this challenging therapeutic endoscopy.
While specific cohort sizes and detailed performance metrics beyond 'feasibility' are not provided in the abstract for this proof-of-concept, the study underscores the potential for AI to introduce a new layer of precision and objectivity into complex endoscopic interventions, paving the way for more rigorous quality control and training paradigms.
Clinical LLMs & Multimodal AI · 2026-10-24 · PubMed / The Lancet. Digital health
FAHR-Face: Clinical Foundation AI Models Extract Multi-System Health Biomarkers from Facial Photographs
Recent advances in deep learning have demonstrated that human facial phenotypes encapsulate intricate physiological, metabolic, and biological aging signals. In a landmark study published in The Lancet Digital Health, investigators led by researchers from Mass General Brigham and Harvard Medical School introduced FAHR-Face (Foundation Artificial Intelligence Models for Health Recognition by Use of Face Photographs), a self-supervised and multitask foundation architecture designed to extract systemic clinical biomarkers directly from standard 2D facial photography. By pretraining visual transformers across large-scale facial datasets linked with deep electronic health records, the investigators developed a generalizable computational platform capable of phenotyping across multiple organ systems without reliance on specialized imaging modalities. The study evaluated FAHR-Face across diverse multi-institutional cohorts to benchmark its capacity for predicting chronological age gaps, metabolic dysregulation, cardiorespiratory endpoints, and all-cause mortality. The architecture demonstrated robust zero-shot and few-shot transfer learning, outperforming conventional single-task convolutional networks in identifying latent systemic pathology. This investigation shifts the paradigm of facial biometric analysis from cosmetic or genetic syndromic dysmorphology screening to systemic, longitudinal health risk stratification and passive screening in outpatient and primary care environments.
Oncology AI · 2026-10-24 · PubMed / DEN open
AI-Assisted Diagnosis of Early Gastric Cancer: The Synergistic Role of Linked-Color Imaging
A pilot study investigated the synergistic benefit of Linked-Color Imaging (LCI) in conjunction with artificial intelligence (AI) for the diagnosis of early gastric cancer. The research, employing propensity score adjustment to mitigate confounding variables, aimed to evaluate whether the enhanced visualization offered by LCI could significantly improve AI's diagnostic accuracy in identifying subtle lesions indicative of early-stage malignancy. This study addresses a critical clinical need for more precise and timely detection of early gastric cancer, which is often challenging to differentiate from benign conditions during conventional endoscopy.
Early gastric cancer diagnosis remains pivotal for patient prognosis, with endoscopic resection options available for superficial lesions. However, the visual subtleties require highly skilled endoscopists. The integration of AI promises to augment human capabilities, and this pilot study specifically explored how LCI, a image-enhanced endoscopy technique known for accentuating mucosal surface changes and vascular patterns, could further optimize AI performance. The findings suggest that combining LCI with AI holds a distinct advantage in enhancing diagnostic confidence and accuracy for these critical lesions.
Pathology & Precision Oncology AI · 2026-10-23 · Nature Medicine
Whole-Slide Foundation Models in Computational Pathology Predict Multi-Organ Immunotherapy Response
A milestone international multi-center study published in Nature Medicine validates a self-supervised gigapixel whole-slide pathology foundation model across 14,800 patients with solid tumors. The computational model directly predicts immune checkpoint inhibitor (anti-PD-1/PD-L1) clinical response and progression-free survival directly from routine hematoxylin and eosin (H&E) biopsy slides without requiring expensive multi-gene expression profiling or specialized immunohistochemistry assays.
Validated across non-small cell lung cancer, triple-negative breast cancer, melanoma, and gastric adenocarcinoma cohorts across 12 medical institutions in North America and Europe, the algorithm achieved a combined C-index of 0.82 for 2-year progression-free survival, significantly outperforming conventional PD-L1 Tumor Proportion Scores (TPS C-index 0.61).
Regulatory & FDA Clearances · 2026-10-20 · FDA Digital Health Center of Excellence
FDA Issues Expanded Final Guidance on Lifecycle Management for Adaptive Generative AI Diagnostics
The US Food and Drug Administration (FDA) Digital Health Center of Excellence has released an expanded final guidance framework detailing regulatory clearance pathways for adaptive generative AI and multi-agent clinical decision support systems. Departing from static 'locked-box' algorithm clearances, the new guidance establishes formal Predetermined Change Control Plans (PCCPs) that permit continuous learning models to update weights based on localized hospital EHR data.
The regulatory update is hailed by health informatics leaders as the most consequential modernization of medical device oversight in over a decade, establishing clear safety guardrails for ambient clinical copilots and autonomous diagnostic triage systems.
Cardiology & Point-of-Care AI · 2026-10-16 · The Lancet Digital Health
Autonomous Point-of-Care Echocardiography Reduces 30-Day Heart Failure Readmissions by 28%
A 1-year prospective multi-center randomized controlled trial published in The Lancet Digital Health investigated whether equipping general ward nurses and outpatient heart failure clinics with AI-guided handheld echocardiography reduces acute hospital readmissions. Enrolling 3,240 patients discharged following acute decompensated heart failure across 16 health systems, the intervention group underwent routine nurse-administered POCUS scans during follow-up visits.
The trial demonstrated a 28.4% relative reduction in 30-day all-cause hospital readmission (14.2% vs. 19.8%, p = 0.0003) and a 35% decrease in emergency department visits, primarily driven by earlier detection of asymptomatic subclinical pulmonary congestion and timely diuretic titration.
Clinical LLMs & Emergency AI · 2026-10-12 · JAMA Internal Medicine
Real-Time Ambient Voice LLMs Reduce Diagnostic Discrepancies During Emergency Department Handoffs
A randomized crossover simulation and prospective observational trial published in JAMA Internal Medicine evaluated the impact of ambient clinical voice LLMs on inter-shift physician sign-outs and handoffs across three high-volume urban emergency departments. Patient handoffs between departing and oncoming emergency physicians have long been identified by the Joint Commission as a primary root cause of sentinel diagnostic errors, medication lapses, and critical test result omissions.
The ambient LLM listening system generated structured I-PASS handoff dossiers in real time, reducing critical diagnostic omissions by 64% and cutting shift transition duration by 31%.
Clinical LLMs & Hospital AI · 2026-09-13 · Reuters Health
US Hospital Networks Deploy Autonomous AI Scribes as Scribe-to-Physician Ratios Plummet
In a nationwide clinical operations shift reported across US academic and community health networks, major health systems—including Kaiser Permanente, Mayo Clinic Health System, and Providence—have scaled ambient clinical voice AI scribes to over 24,000 outpatient physicians. Facing catastrophic rates of clinician burnout and an estimated 2.8 hours of nightly 'pajama time' spent completing electronic health record (EHR) charts, early health system audits show ambient LLM scribes reduce physician documentation burden by 72% while increasing direct patient face-to-face eye contact.
The widespread rollout represents one of the largest immediate deployments of generative artificial intelligence in daily clinical practice to date, shifting generative AI from experimental pilots to frontline standard-of-care infrastructure.
Clinical LLMs & Hospital AI · 2026-09-12 · STAT News
Multi-Site Hospital Trial Reveals Discrepancies in Sepsis Prediction AI Algorithms
An investigative clinical report published by STAT News highlights critical new findings from a prospective multi-state evaluation of commercial and proprietary sepsis-early-warning AI algorithms. While vendor benchmark studies initially reported AUROCs exceeding 0.90, real-world deployment across 18 diverse academic, suburban, and rural community hospitals revealed severe generalization drop-offs, with real-world AUROCs fluctuating between 0.68 and 0.79.
The findings have triggered calls from clinical safety watchdogs for stringent post-market calibration standards before sepsis models are allowed to trigger automatic antibiotic orders or intensive care rapid response teams.
Drug Discovery & Antimicrobial AI · 2026-09-11 · MIT Technology Review
Generative AI Discovers Candidate Antibiotics Effective Against Critical WHO-Priority Pathogens
In a groundbreaking drug discovery milestone reported by MIT Technology Review, an international collaborative consortium led by MIT, Broad Institute, and McMaster University utilized generative structural biology foundation models to design and synthesize novel antibiotic molecules capable of neutralizing drug-resistant Acinetobacter baumannii and MRSA.
The computational architecture screened over 100 million chemical compounds in under 48 hours, isolating an unprecedented chemical class that disrupts bacterial proton motive force without causing toxicity in mammalian tissue models.
Stroke & Acute Neuro AI · 2026-09-10 · BBC News Health
UK NHS Expands Stroke AI Brain-Imaging Network to 110 Acute Emergency Centers
The UK National Health Service (NHS) has published a 2-year nationwide clinical audit on the deployment of deep learning stroke imaging algorithms across 110 acute hospital trusts. Reported by BBC News Health, the real-world data demonstrates that automated AI analysis of non-contrast CT and CT angiography scans tripled the rate of rapid thrombectomy referrals and reduced door-to-treatment decision times by over 60 minutes.
By enabling instant mobile sharing of 3D brain perfusion maps between frontline emergency physicians and on-call interventional neurosurgeons, the network has prevented severe permanent neurological disability in thousands of ischemic stroke patients.
Regulatory & FDA Approvals · 2026-09-10 · FDA Digital Health
FDA Digital Health Update: Guidance on Lifecycle Management for Adaptive Generative AI Devices
The US Food and Drug Administration (FDA) Digital Health Center of Excellence published revised draft guidance establishing rigorous Pre-Determined Change Control Plans (PCCPs) for generative AI and continuously learning machine learning algorithms in clinical decision support software (SaMD).
Regulatory & FDA Clearances · 2026-09-09 · Bloomberg Health
FDA Grants De Novo Authorization for Autonomous Point-of-Care Handheld Cardiac Ultrasound AI
The US Food and Drug Administration (FDA) has granted De Novo regulatory clearance for an autonomous point-of-care ultrasound (POCUS) artificial intelligence system, reported by Bloomberg Health AI. The clearance authorizes non-specialist clinical personnel—including registered nurses, paramedics, and triage medical assistants—to acquire diagnostic-quality transthoracic echocardiography views guided by real-time spatial AI navigation.
The landmark regulatory decision is expected to democratize bedside cardiac assessment across emergency rooms, rural clinics, and ambulatory heart failure management programs.
Clinical LLMs & Multimodal AI · 2026-09-08 · Nature Medicine
Multimodal Foundation Models in Clinical Triage: Validating EHR and Imaging Fusion
A landmark multi-center prospective cohort investigation published in Nature Medicine evaluated the diagnostic accuracy of multimodal foundation models combining longitudinal electronic health records (EHR) with acute computed tomography (CT) scans in emergency department triage.
Across 42,850 consecutive emergency admissions across four tertiary academic centers, the multimodal architecture achieved an AUROC of 0.93 for identifying life-threatening acute decompensations within 12 hours of presentation, significantly outperforming traditional single-modality clinical risk scores (NEWS2 AUROC 0.74, single-slice CT deep learning AUROC 0.81).
Ophthalmology & Primary Care AI · 2026-09-06 · The Lancet Digital Health
Autonomous AI Screening for Diabetic Retinopathy in Primary Care: 3-Year Real-World Outcomes
A 3-year prospective multi-center trial published in The Lancet Digital Health evaluated the real-world diagnostic yield and clinical adherence of autonomous diagnostic AI fundus photography deployed across 120 primary care and community health clinics.
Screening 64,300 diabetic patients, the autonomous AI system achieved 96.1% sensitivity and 92.4% specificity for referable diabetic retinopathy and diabetic macular edema, closing annual retinal examination adherence gaps by 41.8%.
Cardiology & Electrophysiology AI · 2026-09-04 · PubMed / JACC
AI-Augmented 12-Lead ECG for Early Detection of Left Ventricular Systolic Dysfunction
A multi-center clinical validation study published in the Journal of the American College of Cardiology (JACC) demonstrated that a convolutional neural network applied to standard 10-second 12-lead electrocardiograms reliably detects asymptomatic Left Ventricular Systolic Dysfunction (LVEF ≤ 40%) with an AUROC of 0.94.
In a pragmatic randomized trial of 22,000 ambulatory patients, AI-enabled ECG screening led to a 34% relative increase in early diagnosis of subclinical heart failure with reduced ejection fraction.